Concepedia

Mark Powell

MP

34

Publications

2.1K

Citations

23

H-Index

1978

Active since

Affiliations

Dana-Farber Cancer Institute(Current)

AstraZeneca (United States)

Harvard University

Northwestern University

Wilmington University

Mark Powell is an author at Dana-Farber Cancer Institute specializing in medicine, oncology, and radiation oncology.

Top concepts

Publications per year

1978–2023

34

Publications

34

Phase II Study of Sorafenib in Combination With Docetaxel and Cisplatin in the Treatment of Metastatic or Advanced Gastric and Gastroesophageal Junction Adenocarcinoma: ECOG 5203

Weijing Sun, Mark Powell, Peter J. O’Dwyer et al. · Journal of Clinical Oncology · 2010 · 216 citations · Full text

Long‐term psychosocial adjustment of older vs younger survivors of breast and endometrial cancer

Alice B. Kornblith, Mark Powell, Meredith M. Regan et al. · Psycho-Oncology · 2007 · 215 citations

ARCTIC: durvalumab with or without tremelimumab as third-line or later treatment of metastatic non-small-cell lung cancer

David Planchard, Niels Reinmuth, Jürgen R. Fischer et al. · Annals of Oncology · 2020 · 156 citations · Full text

A randomized phase III study of gemcitabine in combination with radiation therapy versus gemcitabine alone in patients with localized, unresectable pancreatic cancer: E4201

P. J. Loehrer, Mark Powell, Higinia R. Cárdenes et al. · Journal of Clinical Oncology · 2008 · 154 citations

, , +11

Dynamic contrast enhanced magnetic resonance scanning as a predictor of response to accelerated radiotherapy for advanced head and neck cancer.

Peter Hoskin, M.I. Saunders, K. Goodchild et al. · British Journal of Radiology · 1999 · 134 citations

, , +20

Rows per page

1–5 of 34